An HIV vaccine plus broadly neutralizing antibodies and an immune-stimulating drug helped control HIV after stopping antiretrovirals.

Researchers tout effectiveness of method that wouldn’t require lifetime of medication

Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a person stops taking antiviral pills.

Two new studies provide insights into a possible cure for HIV, and feature the work of researchers from the UW and Fred Hutchinson Cancer Center.

UCSF researchers have made strides toward an HIV cure, showing experimental immunotherapy can help control the virus without long-term antiretroviral therapy (ART). In a small study, 7 of 10 participa...

Specific class of immune cells help keep virus at bay for months or years—even in the absence of drugs

Antiretroviral drugs that prevent HIV and keep it in check have been transformative, but a cure has been a long-sought goal.

Seven of 10 volunteers kept HIV at bay for months after stopping meds, a rare result scientists call a major step toward a functional cure.

Nature - Correlates of HIV-1 control after combination immunotherapy

Antiretroviral drugs that prevent HIV and keep it in check have been transformative, but a cure has been a long sought goal.

Plus: what I wrote in Science about the revised Schedule F

Fights over research spending and pending court rulings loom large

NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Notice of Civil Rights Term and Condition of Award NOT-OD-25-090. NIH

Elon Musk promised to preserve lifesaving aid to foreign children. Then the Trump administration quietly canceled it.

The attacks on HIV research are just the beginning of unraveling decades of progress.

Reassignment letters come as reduction in force begins

TO THE AMERICAN PEOPLE We all rely on science. Science gave us the smartphones in our pockets, the navigation systems in our cars, and life-saving medical care. We count on engineers when we drive acr...

The best-selling author “got a little emotional” while talking with The Times about tuberculosis. Listen to the conversation.

Nearly 2,000 scientists urged that Congress restore funding to federal agencies decimated by recent cuts.

Staff at biomedical agency worry about political interference in setting priorities

Federal officials cited the end of the Covid-19 pandemic in halting the research. But much of the work was focused on preventing outbreaks of other pathogens.

Until I left last week, I led the CDC’s public health messaging. Now we need something to replace it.